Patrick Caplazi
9PUBLICATIONS
82CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 07, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.Rojo A Ratsimandresy, Emma Doran, Hart S Dengler
|May 26, 2023
LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung.Hsiao-Yen Ma, Qingling Li, Weng Ruh Wong
|Dec 30, 2022
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone.Hsiao-Yen Ma, Jason A Vander Heiden, Salil Uttarwar
|Aug 05, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.Tianhe Sun, Zhiyu Huang, Wei-Ching Liang
|Nov 20, 2020
Neutrophil serine protease 4 is required for mast cell-dependent vascular leakage.Andrew P AhYoung, Sterling C Eckard, Alvin Gogineni
|Apr 22, 2018
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.Teresita L Arenzana, Steve Lianoglou, Akiko Seki
Pageof 2
Frequent Collaborators
3 joint publications
Hans D Brightbill
3 joint publications
Jason A Vander Heiden
2 joint publications
Daryle J DePianto
2 joint publications
Jason A Hackney
2 joint publications
Katrina B Morshead
2 joint publications
Rajbharan Yadav
2 joint publications
Tianhe Sun
2 joint publications
Merone Roose-Girma
2 joint publications
Dhaya Seshasayee
2 joint publications
Jennie R Lill
